Last update:

Weight management news

Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope

Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted facial hair—the same puzzling symptoms that plagued her mom for decades and that no doctor could piece ...

New obesity definitions reveal ill health more accurately than body mass index

Traditionally, obesity has been classified primarily using BMI, a measure of weight relative to height that provides limited information about whether excess fat is actually affecting a person's health. BMI levels have historically ...

Unexpected brain mechanism challenges assumptions about GLP-1s

For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10% to 15% or more. Despite their success, ...

Can't stick to a diet? Try intermittent fasting for weight loss

Yo-yo dieters who struggle to lose weight and keep it off may achieve better results by following an intermittent fasting diet, rather than traditional calorie counting. An Adelaide University study focusing on the psychological ...

Why weight‑loss drugs don't work for some people

Weight-loss jabs are the latest craze for shedding a few pounds. Their effect has been dramatic, with drugs such as Ozempic and Wegovy (semaglutide) causing users to lose up to 15% of their body fat on average.

Beyond GLP-1s: The next chapter of obesity care

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most pressing chronic diseases.

An economic case for teen weight-loss surgery

Metabolic and bariatric surgery for teens with severe obesity was found to be cost-effective over 10 years, according to a new analysis from Ann & Robert H. Lurie Children's Hospital of Chicago published in JAMA Network Open. ...

Semaglutide linked to lower bone fracture risk

In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared with other anti-obesity medications, according to a study presented at ENDO 2026, the Endocrine ...

Hip dips: What are they and can you really get rid of them?

Hip dips are having a moment. The perfectly normal indentations that sit below your hips on the outer thigh have become the latest body feature to be scrutinized, fixed and agonized over on social media. But what are they? ...